Safety of tPA + Transcranial Emission of Low-Energy Lasers for Acute Stroke Recovery - Results (P4.219)

Conclusion: Transcranial Laser in this small exploratory study was well tolerated in combination with IV tPA. Larger studies are needed to explore if the combination of LASER therapy plus tPA is safe and shows better outcome than IV tPA alone.Study supported by NIH Grant P50 NS044148Clinical Trial Registry: NCT01220739Disclosure: Dr. Hemmen has nothing to disclose. Dr. Raman has nothing to disclose. Dr. Sen has received personal compensation for activities with Genentech Inc., Sanofi Aventis Pharmaceutical Inc., Bristol-Myers Squibb Co., and Boehringer Ingelheim Pharmaceuticals Inc. Dr. Sen has received research support from Genentech Inc. Dr. Geraghty has nothing to disclose. Dr. Rapp has nothing to disclose. Dr. Richeri has nothing to disclose. Dr. Meyer has received personal compensation for activities with The Medicine's Company as a speaker and advisory panel member, and with Genentech as a speaker. Dr. Zivin has received personal compensation for activities with Ambit, AstraZeneca, CytRX, Merck, Johnson & Johnson, PhotoThera, PhRMA, Pfizer, and Remedy Pharmaceutical. Dr. Fanale has received personal compensation for activities with Genentech Inc.
Source: Neurology - Category: Neurology Authors: Tags: Cerebrovascular Disease and Interventional Neurology: Acute Stroke Thrombolysis Source Type: research